menu
ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

ACURA PHARMACEUTIC (ACUR)
0.3601 0.02 (5.91%)  12-13 14:33
Open: 0 Prev Close: 0.34
High: 0 Low: 0
Volume: 0 Market Cap: 7M
Year High: 1.4 Year Low: 0
Stock Technical Analysis
Overall       
Targets Six months: 0.5154    One year: 0.5957
Supports Support1: 0.3300   Support2: 0.2746
Resistances Resistance1: 0.4412    Resistance2: 0.5100 
Pivot Point 0.3920 
Moving Averages MA(5): 0.3560      MA(20): 0.4008 

MA(100): 0.4389  -1     MA(250): 0.5344 
MACD MACD(12,26): -0.020      Signal(12,26,9): -0.014 
Stochastic Oscillator %K(14,3): 13.367      %D(3): 12.256 
RSI RSI(14): 35.968 
52-Week High: 1.4000  Low: 0.3300  Change(%): -59
Average Volume(K) 3-Month: 1065  10-Days: 1029
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is below its mid-term; and below long term moving averages. From the relationship between price and moving averages; we can see that: this stock is BEARISH in short-term; and BEARISH in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed above bottom band by 23.4%; Bollinger Bands are 55.3% wider than normal.The large width of the bands suggest high volatility as compared to ACUR's normal range. The bands have been in this wide range for 2 bars. This is often a sign that the current trend may be ending.

Stoxline

Stock Chart

Top 100 stocks

Stock News
Acura Pharmaceuticals Inc.
Sun, 13 Feb 2011 05:27:45 GMT

Acura Pharmaceuticals Advances LTX-03 and its LIMITx™ Technology
Mon, 09 Oct 2017 10:07:30 GMT

Acer Therapeutics Inc. (ACER) stock RSI touches to 17.76 and Acura ...
Wed, 13 Dec 2017 18:33:45 GMT

Acura Pharmaceuticals and MainPointe Pharmaceuticals Announce Deal for Nexafed ...
Fri, 17 Mar 2017 10:07:30 GMT

Acura Pharmaceuticals Raises $4.0 Million in a Private Placement
Mon, 24 Jul 2017 20:37:30 GMT

Acura Pharmaceuticals Exploring Strategic Alternatives
Tue, 03 Jan 2017 21:11:15 GMT

Acura Pharmaceuticals Partners With Egalet Corporation to Commercialize ...
Thu, 08 Jan 2015 11:03:45 GMT

Acura Pharmaceuticals Initiates Clinical Study of Meth-Resistant Nexafed ...
Mon, 16 Feb 2015 11:26:15 GMT

Acura Pharmaceuticals Advances LTX-04 and its LIMITx™ Technology
Wed, 28 Jun 2017 20:03:45 GMT

Acura Pharmaceuticals Presenting New LIMITx™ Clinical Data at the 19th Annual ...
Mon, 11 Sep 2017 10:30:00 GMT